General
Preferred name
CINACALCET
Synonyms
CINACALCET HYDROCHLORIDE ()
Cinacalcet HCl ()
AMG-073 hydrochloride ()
AMG-073 HCl ()
AMG 073 ()
AMG 073 (Cinacalcet) ()
Sensipar ()
Cinacalcet HCl ()
Cinacalcet (hydrochloride) ()
AMG-073 (hydrochloride) ()
Cinacalcet (AMG-073) HCl ()
Mimpara, Sensipar,AMG-073 ()
AMG073, Sensipar, Cin ()
AMG073 HCL ()
AMG073 HYDROCHLORIDE ()
CINACALCET ACCORDPHARMA ()
CINACALCET MYLAN ()
Mimpara ()
PARAREG ()
AMG073 ()
AMG-073 ()
KRN-1493 ()
KRN1493 ()
Cinacalcet (hydrochloride) ()
Cinacalcet-d3 (hydrochloride) ()
P&D ID
PD009594
CAS
364782-34-3
226256-56-0
1025064-29-2
2749807-20-1
Tags
available
drug
Approved by
EMA
FDA
First approval
2004
Drug indication
prostate adenocarcinoma
Secondary hyperparathyroidism
Hyperparathyroidism
Kidney disease
Drug Status
approved
investigational
withdrawn
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Cinacalcet is a positive allosteric activator of the calcium-sensing receptor (CaSR), thus improving the effect of calcium on tissues expressing this receptor.
(GtoPdb)
MOA
Cinacalcet directly lowers parathyroid hormone levels by increasing the sensitivity of the calcium sensing receptors to activation by extracellular calcium, resulting in the inhibition of PTH secretion. The reduction in PTH is associated with a concomitant decrease in serum calcium levels.
DESCRIPTION
Cinacalcet (AMG 073) is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease research.
PRICE
35
DESCRIPTION
Cinacalcet hydrochloride (AMG-073 hydrochloride) is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease treatment.
PRICE
35
DESCRIPTION
Cinacalcet is the first calcimimetic drug approved by the United States Food and Drug Administration for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Cinacalcet (AMG 073) is an orally active, allosteric Ca receptor (CaR) agonist used in the treatment of cardiovascular disease.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Cinacalcet is a calcimimetic and an allosteric agonist of the calcium-sensing receptor. Cinacalcet has been used in the treatment of secondary hyperparathyroidism due to end-stage renal disease and hypercalcemia in patients with parathyroid carcinoma.
(Enamine Bioactive Compounds)
DESCRIPTION
G protein-biased D2 partial agonist
(Tocris Bioactive Compound Library)
DESCRIPTION
Cinacalcet hydrochloride (AMG-073 hydrochloride) is a naphthalene derivative and calcimimetic agent that enhances the sensitivity of parathyroid gland calcium-sensing receptors to serum calcium, thereby reducing parathyroid hormone secretion and decreasing serum calcium in the treatment of parathyroid diseases.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
37
BOC Sciences Bioactive Compounds
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
EUbOPEN Chemogenomics Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
Natural product-based probes and drugs
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
149
Molecular Weight
357.17
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
1
Rotatable Bonds
6
Ring Count
3
Aromatic Ring Count
3
cLogP
6.14
TPSA
12.03
Fraction CSP3
0.27
Chiral centers
1.0
Largest ring
6.0
QED
0.52
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
calcium sensing receptor agonist
Agonist
Calcium-Sensing Receptor (CaSR) Agonists
calcium channel activator
Target
Calcium sensing receptor
CaSR
Calcium Channel
Primary Target
Calcium-Sensing Receptor
Member status
member
Indication
hyperparathyroidism, chronic kidney disease (CKD), parathyroid carcinoma, hypercalcemia
Disease Area
endocrinology, nephrology, oncology
ATC
H05BX01
Therapeutic Indication
Hyperparathyroidism
Therapeutic Class
Hormone Therapy
Calcimimetics
Pathway
GPCR/G protein
Recommended Cell Concentration
1 uM
Source data

